Breaking News
January 19, 2019 - FDA Approves Ontruzant (trastuzumab-dttb), a Biosimilar to Herceptin
January 19, 2019 - Tobacco use linked with higher use of opioids and sedatives
January 19, 2019 - Study delves deeper into developmental dyslexia
January 19, 2019 - Anti-vaccination movement one of the top health threats in 2019 says WHO
January 19, 2019 - Newly developed risk score more effective at identifying type 1 diabetes
January 19, 2019 - Highly effective protocol to prepare cannabis samples for THC/CBD analysis
January 19, 2019 - Prinston Pharmaceutical Inc. Issues Voluntary Nationwide Recall of Irbesartan and Irbesartan HCTZ Tablets Due to Detection of a Trace Amount of Unexpected Impurity, N-Nitrosodiethylamine (NDEA) in the Products
January 19, 2019 - How does solid stress from brain tumors cause neuronal loss, neurologic dysfunction?
January 19, 2019 - $14.7 million partnership to supercharge vaccine development
January 19, 2019 - Ian Fotheringham receives Charles Tennant Memorial Lecture award
January 19, 2019 - Brain vital signs detect neurophysiological impairments in players with concussions
January 19, 2019 - Lack of job and poor housing conditions increased likelihood of people attending A&E
January 19, 2019 - Novel targeted drug delivery system improves conventional cancer treatments
January 19, 2019 - Rutgers study finds gene responsible for spread of prostate cancer
January 19, 2019 - Complications Higher Than Expected for Invasive Lung Tests
January 19, 2019 - 3-D printed implant promotes nerve cell growth to treat spinal cord injury
January 19, 2019 - Automated texts lead to improved outcomes after total knee or hip replacement surgery
January 19, 2019 - Poor cardiorespiratory fitness could increase risk of future heart attack, finds new study
January 19, 2019 - Drinking soft drinks while exercising in hot weather may increase risk of kidney disease
January 19, 2019 - Formlabs 3D prints anatomical models
January 19, 2019 - Heart-Healthy Living Also Wards Off Type 2 Diabetes
January 19, 2019 - Teaching Kids to Be Smart About Social Media (for Parents)
January 19, 2019 - Metabolite produced by gut microbiota from pomegranates reduces inflammatory bowel disease
January 19, 2019 - Researchers examine how spray from showers and toilets expose us to disease causing bacteria
January 19, 2019 - Behavioral experiments confirm that additional neurons improve brain function
January 19, 2019 - New study compares performance of real-time infectious disease forecasting models
January 19, 2019 - Obesity can be risk factor for developing renal cell carcinoma, confirms study
January 19, 2019 - New regulation designs on cigarette packs direct smokers’ attention to health warnings
January 19, 2019 - QIAGEN receives first companion diagnostic approval in Japan
January 19, 2019 - Study explores role of Dunning-Kruger effect in anti-vaccine attitudes
January 19, 2019 - Newly identified subset of immune cells may be key to fighting chronic inflammation
January 19, 2019 - New immune response regulators discovered
January 18, 2019 - Poor blood oxygenation during sleep predicts chance of heart-related death
January 18, 2019 - First international consensus on the diagnosis and management of fibromuscular dysplasia
January 18, 2019 - Rapid resistance gene sequencing technology can hasten identification of antibiotic-resistant bacteria
January 18, 2019 - Researchers develop artificial enzymatic pathway for synthesizing isoprenoids in E. coli
January 18, 2019 - Scientists advise caution in immunotherapy research
January 18, 2019 - How children across the world develop language
January 18, 2019 - Columbia Medical Student Receives McDonogh Scholarship
January 18, 2019 - Secretive ‘Rebate Trap’ Keeps Generic Drugs For Diabetes And Other Ills Out Of Reach
January 18, 2019 - Plant based diet could be the best option for the planet says commission
January 18, 2019 - New conservation practice could reduce nitrogen from agricultural drainage, study shows
January 18, 2019 - UIC researchers receive $1.7 million NCI grant to study Southeast Asian fruit
January 18, 2019 - New study determines the fate of DNA derived from genetically modified food
January 18, 2019 - Scientists develop new gene therapy that prevents axon destruction in mice
January 18, 2019 - Study finds critically low HPV vaccination rates among younger adolescents in the U.S.
January 18, 2019 - Brain cells involved in memory play key role in reducing future eating behavior
January 18, 2019 - Risk for Conversion of MS Varies With Different Therapies
January 18, 2019 - Investigational cream may help patients with inflammatory skin disease
January 18, 2019 - Medical school news office receives six writing awards | News Center
January 18, 2019 - County By County, Researchers Link Opioid Deaths To Drugmakers’ Marketing
January 18, 2019 - Research reveals risk for developing more than one mental health disorder
January 18, 2019 - Scientists discover a dramatic pattern of bone growth in female mice
January 18, 2019 - Study finds link between lengthy periods of undisturbed maternal sleep and stillbirths
January 18, 2019 - New nuclear medicine method could improve detection of primary and metastatic melanoma
January 18, 2019 - Combination therapy shows high efficacy in treating people with leishmaniasis and HIV
January 18, 2019 - Health Tip: Don’t Ignore Changes in Skin Color
January 18, 2019 - Dietary Recommendations for Healthy Children
January 18, 2019 - Eliminating the latent reservoir of HIV
January 18, 2019 - Pain From The Government Shutdown Spreads. This Time It’s Food Stamps
January 18, 2019 - Newly discovered regulatory mechanism helps control fat metabolism
January 18, 2019 - New rapid blood tests could speed up TB diagnosis, save the NHS money
January 18, 2019 - Researchers develop intelligent system for ‘tuning’ powered prosthetic knees
January 18, 2019 - Monoclonal antibody pembrolizumab prolongs survival in patients with squamous cell carcinoma
January 18, 2019 - Maintaining an active lifestyle in older age could prevent dementia
January 18, 2019 - New research detects mosquito known to transmit malaria for the first time in Ethiopia
January 18, 2019 - Researchers identify new genes linked to development of age-related macular degeneration
January 18, 2019 - Computerized method helps better protect pharma patents
January 18, 2019 - New guidelines to make swallowing safer for people in Australian nursing homes
January 18, 2019 - Lumex Instruments’ RA-915AM monitor installed at Hg treatment plant in Almadén, Spain
January 18, 2019 - ACCC survey finds multiple threats to growth of cancer programs
January 18, 2019 - Meeting the challenge of engaging men in HIV prevention and treatment
January 18, 2019 - Furloughed Feds’ Health Coverage Intact, But Shutdown Still Complicates Things
January 18, 2019 - Experts discuss various aspects on health risks posed by fumigated containers
January 18, 2019 - Researchers use gene-editing tool CRISPR/Cas9 to limit impact of parasitic diseases
January 18, 2019 - Alpha neurofeedback training could be a means of enhancing learning success
January 18, 2019 - Innovative ‘light’ method demonstrates positive results in fight against malignant tumors
January 18, 2019 - The cytoskeleton of neurons found to play role in Alzheimer’s disease
January 18, 2019 - New resource-based approach to improve HIV care in low- and middle-income countries
January 18, 2019 - Bedfont appoints Dr Jafar Jafari as first member of the Gastrolyzer Medical Advisory Board
Researchers receive $1.2 million grant to test potential treatment for metastatic breast cancer

Researchers receive $1.2 million grant to test potential treatment for metastatic breast cancer

image_pdfDownload PDFimage_print

A team of Medical University of South Carolina (MUSC) Hollings Cancer Center researchers received a three-year, $1.2 million grant from the U.S. Department of Defense (DOD) to test a potential therapeutic antibody that could block breast cancer growth with fewer side effects, opening up potential for future drug development. The team will deploy innovative molecular imaging tools to study a crucial mechanism that appears to drive tumor development.

The study aims to find better ways to treat metastatic breast cancer that could replace current therapies, some of which have life-threatening side effects. Core to the work is Hollings Cancer Center researcher Nancy DeMore, M.D., a leading expert in angiogenesis and therapeutics created for breast cancer.

Angiogenesis, a key phase in malignant growth, involves how blood vessels form, develop and create a network to perfuse different types of solid tumors. Tumors need a blood supply to receive their nutrients and also as an escape route to metastasize to other organs, explains Ann-Marie Broome, Ph.D., director of HCC’s Small Animal Imaging Center, who’s also involved with the study and part of MUSC’s Department of Cell and Molecular Pharmacology & Experimental Therapeutics.

“We have a great team assembled to study this. The power of molecular imaging is clear. We believe that if you can see it, you can dissect its mechanism of action then treat it and attack it. That’s the greatest impact I see for translational imaging studies. That’s why I’m excited.”

Traditional chemotherapeutic drugs kill rapidly dividing cancer cells, but they can also destroy or damage many healthy cells. Developing less toxic interventions requires changing the target from rapidly-dividing cells to one that is specifically expressed in tumors and not in normal tissue.

DeMore’s laboratory is studying the role a novel angiogenesis factor, a protein known as secreted-frizzled-related protein 2 (SFRP2), plays in breast cancer. “The SFRP2 protein is overexpressed in tumor vessels, and later we found that it was overexpressed in a wide variety of tumors, including breast cancer,” said DeMore, who holds the BMW Endowed Chair in Cancer Research at MUSC.

The thought is to inhibit reactions downstream from SFRP2, selectively blocking tumor blood vessels from growing and reducing toxicity to normal tissue.

In preclinical studies, DeMore’s laboratory discovered that a SFRP2 protein has a novel function. The protein activates a mechanism called calcineurin/NFAT, which is critical in blood vessel and tumor growth.

Now the Hollings Cancer Center team seeks to test whether the calcineurin/NFAT mechanism, rather than other potential mechanisms, is driving breast tumor growth, and whether tumor development can be blocked by targeting this pathway. The researchers have developed a novel humanized antibody that has already proved effective in blocking the calcineurin/NFAT pathway and tumor development in cultured human cell models of breast cancer.

“We hope to find out whether our antibody inhibits tumor growth through the calcineurin/NFAT pathway instead of other pathways,” DeMore said.

The researchers plan to study the humanized antibody in an animal model to learn whether it disrupts the calcineurin/NFAT mechanism, preventing in vivo tumor growth while leaving normal tissue unaffected. Broome said the antibody recognizes a protein found on blood vessels.

“By impacting angiogenesis and blood vessel stability within tumors, we can alter the way these tumors are able to survive in the presence of that antibody. We’re creating a fine balance between cutting off the nutrients and normalizing the vasculature so that the tumors are less likely to progress.”

The researchers will use real-time fluorescence imaging systems to highlight and reveal interactions among protein pathways within tumors that have not been seen using other methods. “The fluorescent systems, which are one of the most sensitive imaging tools available, give us faster, clearer images and more specific answers to the questions that we are asking,” Broome said. “It’s not enough just to know that there is a therapeutic response to the antibody. We want to know why and where there is a response.”

The researchers will corroborate fluorescence imaging findings with other modalities, such as computed tomography (CT) images and bioluminescence tools. Tracking SFRP2 pathways with innovative imaging tools could eventually help clinicians track tumor growth and monitor response to chemotherapy. Another aim of the study is to combine the humanized antibody with other drugs commonly used for breast cancer and look for an additive or synergistic effect.

The DOD grant also supports a related study by Shikhar Mehrotra, Ph.D., investigating whether SFRP2 may also play an important role in immune cell function.

A potential treatment is not yet available for human studies, but the team plans to obtain funding for further drug development that could lead to a Phase I clinical trial.

Source:

http://academicdepartments.musc.edu/newscenter/2018/hcc-metastatic-breast-cancer/index.html

Tagged with:

About author

Related Articles